Federal Supply Schedule 36F79720D0208
- This multiple award IDV was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to procure pharmaceuticals and drugs under GSA's Pharmaceuticals and Drugs Schedule. The prime contractor is Q Biomed Inc. With a potential value of $225,000 and a period of performance through February 2026, the contract aims to deliver 65 I B drugs, pharmaceuticals, and hematology-related products to VA medical treatment facilities in the region. The...
- This multiple award IDV was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to procure pharmaceuticals and drugs under GSA's Pharmaceuticals and Drugs schedule. The prime contractor is Akorn, Inc. With a potential value of $244,163,640 and a period of performance through June 2023, the IDV aims to facilitate orders for Schedule 65 IB products including drugs, pharmaceuticals, and hematology-related items to support VA...
- This multiple award IDV was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to acquire pharmaceuticals and drugs under GSA's Pharmaceuticals and Drugs Schedule. The contract aims to procure a range of drugs, pharmaceuticals, and hematology-related products for $225,000 over its June 2021 to December 2021 period of performance. Oncopeptides, Inc. is the prime contractor tasked with delivering these products and services under...
- This multiple award IDV was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to procure pharmaceuticals and drugs under GSA's Pharmaceuticals and Drugs Schedule. West Therapeutic Development, LLC was awarded the IDV as the prime contractor. The IDV aims to procure a range of drugs, pharmaceuticals, and hematology-related products over a four year period ending in January 2024, with a potential value of $225,000. No set-asides were...
- This multiple award IDV was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to acquire pharmaceuticals and drugs under GSA's Pharmaceuticals and Drugs schedule. Circassia Inc. was awarded the IDV with a potential value of $30.4 million and a period of performance through March 2025. The IDV facilitates the acquisition of drugs, pharmaceuticals, and hematology-related products through task orders or delivery orders issued...
- The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products. The contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The prime contractor is Usantibiotics LLC, a for-profit organization. The contract is an interim agreement with a ceiling value of $25,000.00 and a period of performance through April 1, 2023. The contract does...
- This multiple award IDV was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to procure pharmaceuticals and drugs under GSA's Pharmaceuticals and Drugs Schedule. Hill Dermaceuticals Inc. was awarded the IDV with a potential value of $225,000. No set-aside was used. Products and services must be delivered by January 14, 2023. The IDV aims to procure drugs, pharmaceuticals, and hematology-related products listed in GSA Schedule 65...
- The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products. The contracting agency is the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department of Veterans Affairs. The prime contractor is Quallent Pharmaceuticals Health, LLC, a foreign-owned for-profit manufacturer of goods. The contract has a ceiling value of $25,000.00 and a period of performance through...
- The federal contract IDV award is for pharmaceuticals and drugs under the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule. The multiple award IDV was granted by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Rockwell Medical, Inc. on March 1, 2021, with a potential value of $250,000 and period of performance through December 15, 2022. The IDV facilitates delivery of drugs, pharmaceuticals, and hematology-related products to...
- The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products. The contracting agency is the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 12 (VISN 12). The prime contractor is Reata Pharmaceuticals, Inc., a for-profit organization. The contract has a ceiling value of $25,000.00 and a period of performance ending on October 23, 2023. It is a multiple...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- 36F79720D0208Federal Supply Schedule
- Blanket Purchase Agreements
This multiple award IDV was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 under the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule. The contract aims to procure various drugs, pharmaceuticals, and hematology-related products through May 2023. Baudax Bio, Inc. is the prime contractor with a potential value of $620,400. The original solicitation sought drugs, pharmaceuticals, and related products to support the treatment of veterans within the Veterans Integrated Service Network 12 region. This includes a range of prescription and over-the-counter medications commonly used in clinical settings for pain management, infection treatment, chronic disease maintenance, and other ailments. No set-asides were applied to this multiple award. Places of performance will likely include VA medical centers and outpatient clinics within the local network's jurisdiction.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00009 | Legal Contract Cancellation | $0 | 5/15/23 | |
| P00008 | Supplemental Agreement for work within scope | $0 | 5/3/23 | |
| P00007 | Other Administrative Action | $0 | 12/13/22 | |
| P00006 | Supplemental Agreement for work within scope | $0 | 11/16/22 | |
| P00005 | Supplemental Agreement for work within scope | $0 | 12/7/21 |